Search

everythinglearnresearchcommunity

for

Search:↓

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

Five FDA-approved drugs may help block COVID-19 virus entry.

Five FDA-approved drugs may help block COVID-19 virus entry.

Genetic differences affect how people respond to COVID-19.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Long COVID has severely affected a couple's health, finances, and social life.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Six existing drugs may help block virus entry in COVID-19.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.